市場調査レポート

商品コード

1494582

患者エンゲージメント技術市場の評価：コンポーネント・デリバリータイプ・治療領域・機能・用途・エンドユーザー・地域別の機会および予測 (2017-2031年)

Patient Engagement Technology Market Assessment, By Component, By Delivery Type, By Therapeutic Area, By Functionality, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年06月14日
発行: Market Xcel - Markets and Data
ページ情報: 英文 234 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 652,770円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 826,842円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,189,492円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=145.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の患者エンゲージメント技術の市場規模は、2023年の204億1,000万米ドルから、2024年から2031年の予測期間中は15.08%のCAGRで推移し、2031年には627億8,000万米ドルの規模に成長すると予測されています。

同市場の成長を支えているのは、有利な政府政策の導入、急速な人口増加、さまざまな疾患の流行、モバイルアプリの利用の増加、さまざまな参入事業者間の戦略的パートナーシップです。さまざまな医療施設によるITインフラ強化に向けた投資の増加も、患者エンゲージメント技術の世界の市場規模を押し上げています。これらの技術が提供するシームレスな患者支援により、医療の専門家は患者とのリアルタイムのつながりを確保しながら、患者のアドヒアランスを効果的に追跡することができます。

さらに、患者エンゲージメントのスタートアップに対する大手企業による投資の増加が、今後数年の市場拡大をサポートすると期待されています。2024年4月、ProvidenceはPraia Healthをスピンアウトさせました。Praia Healthは、医療提供者が患者を有益なサービスやリソースにつなげることで、患者との強固な関係を構築できるように設計されたプラットフォームです。Series A資金調達ラウンドはFrist Cressey Venturesによって2,000万米ドルでクローズされ、Providence Ventures, Inc.、SignalFire Management Services, L.L.C.、Epsilon Health Investors, LLCなどが参加しています。このプラットフォームは、断片化されたポイントソリューションやデータソースを統合することを目的としており、これには請求やケア提供、ケアナビゲーション、消費者レベルでの予約などが含まれます。このようなプラットフォームの開発により、患者のペイシェントジャーニーのパーソナライゼーションが可能になり、医療従事者は患者の健康状態を正確に把握できるようになります。

慢性疾患の増加が市場需要を押し上げる：

世界のさまざまな地域で、慢性疾患を抱える患者数が増加していることも、市場の拡大を支える主要な促進要因の1つです。U.S. Centers for Disease Control and Preventionの推計によると、2024年時点で、米国人口の11.6％を占める約3,840万人が糖尿病を患っています。このような疾患の効果的な管理を確実にするために、さまざまな企業が患者中心のエンゲージメントソリューションの開発に投資する見通しです。

当レポートでは、世界の患者エンゲージメント技術の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

市場規模・予測
コンポーネント別
- ソフトウェア
- ハードウェア
- サービス
デリバリータイプ別
- オンプレミス
- ウェブ&クラウドベース
治療領域別
- 健康・ウェルネス
- 慢性疾患管理
- その他
機能別
- コミュニケーション
- ヘルストラッキング・分析
- 請求・支払い
- 手続き
- 患者教育
- その他
用途別
- PHM (Population Health Management)
- 入院患者健康管理
- 外来患者健康管理
- その他
エンドユーザー別
- 医療提供者
- 保険者
- 患者
- その他
地域別
- 北米
- 欧州
- 南米
- アジア太平洋
- 中東・アフリカ
企業別市場シェア

第5章世界の患者エンゲージメント技術市場の展望：地域別

北米
欧州
南米
アジア太平洋
中東・アフリカ

第6章市場マッピング、2023年

コンポーネント別
デリバリータイプ別
治療領域別
機能別
用途別
エンドユーザー別
地域別

第7章マクロ環境と産業構造

需給分析
輸出入分析
バリューチェーン分析
PESTEL分析
ポーターのファイブフォース分析

第8章市場力学

成長推進因子
成長阻害因子 (課題・制約)

第9章規制枠組みとイノベーション

特許情勢
規制当局の承認
イノベーション/新興技術

第10章主要企業の情勢

市場リーダー上位5社の競合マトリックス
市場リーダー上位5社の市場収益分析
M&A・ジョイントベンチャー (該当する場合)
SWOT分析 (参入5社)
特許分析 (該当する場合)

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

Oracle Corporation
IQVIA Holdings Inc.
Koninklijke Philips N.V.
Klara Technologies, Inc.
Oneview Healthcare PLC
Epic Systems Corporation
Lincor Inc.
Orion Health Ltd.
MEDHOST Inc.
Nuance Communications, Inc.

第14章戦略的提言

第15章当社について・免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 3. Global Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 4. Global Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 5. Global Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 6. Global Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 7. Global Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 8. Global Patient Engagement Technology Market Share (%), By Region, 2017-2031F
Figure 9. North America Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 10. North America Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 11. North America Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 12. North America Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 13. North America Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 14. North America Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 15. North America Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 16. North America Patient Engagement Technology Market Share (%), By Country, 2017-2031F
Figure 17. United States Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 18. United States Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 19. United States Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 20. United States Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 21. United States Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 22. United States Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 23. United States Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 24. Canada Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 25. Canada Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 26. Canada Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 27. Canada Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 28. Canada Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 29. Canada Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 30. Canada Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 31. Mexico Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 32. Mexico Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 33. Mexico Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 34. Mexico Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 35. Mexico Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 36. Mexico Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 37. Mexico Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 38. Europe Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 39. Europe Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 40. Europe Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 41. Europe Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 42. Europe Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 43. Europe Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 44. Europe Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 45. Europe Patient Engagement Technology Market Share (%), By Country, 2017-2031F
Figure 46. Germany Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 47. Germany Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 48. Germany Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 49. Germany Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 50. Germany Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 51. Germany Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 52. Germany Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 53. France Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 54. France Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 55. France Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 56. France Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 57. France Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 58. France Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 59. France Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 60. Italy Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 61. Italy Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 62. Italy Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 63. Italy Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 64. Italy Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 65. Italy Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 66. Italy Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 67. United Kingdom Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 68. United Kingdom Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 69. United Kingdom Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 70. United Kingdom Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 71. United Kingdom Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 72. United Kingdom Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 73. United Kingdom Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 74. Russia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 75. Russia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 76. Russia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 77. Russia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 78. Russia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 79. Russia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 80.
Figure 81. Russia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 82. Netherlands Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 83. Netherlands Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 84. Netherlands Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 85. Netherlands Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 86. Netherlands Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 87. Netherlands Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 88. Netherlands Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 89. Spain Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 90. Spain Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 91. Spain Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 92. Spain Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 93. Spain Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 94. Spain Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 95. Spain Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 96. Turkey Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 97. Turkey Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 98. Turkey Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 99. Turkey Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 100. Turkey Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 101. Turkey Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 102. Turkey Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 103. Poland Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 104. Poland Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 105. Poland Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 106. Poland Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 107. Poland Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 108. Poland Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 109. Poland Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 110. South America Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 111. South America Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 112. South America Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 113. South America Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 114. South America Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 115. South America Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 116. South America Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 117. South America Patient Engagement Technology Market Share (%), By Country, 2017-2031F
Figure 118. Brazil Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 119. Brazil Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 120. Brazil Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 121. Brazil Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 122. Brazil Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 123. Brazil Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 124. Brazil Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 125. Argentina Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 126. Argentina Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 127. Argentina Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 128. Argentina Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 129. Argentina Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 130. Argentina Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 131. Argentina Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 132. Asia-Pacific Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 133. Asia-Pacific Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 134. Asia-Pacific Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 135. Asia-Pacific Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 136. Asia-Pacific Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 137. Asia-Pacific Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 138. Asia-Pacific Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 139. Asia-Pacific Patient Engagement Technology Market Share (%), By Country, 2017-2031F
Figure 140. India Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 141. India Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 142. India Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 143. India Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 144. India Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 145. India Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 146. India Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 147. China Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 148. China Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 149. China Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 150. China Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 151. China Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 152. China Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 153. China Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 154. Japan Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 155. Japan Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 156. Japan Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 157. Japan Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 158. Japan Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 159. Japan Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 160. Japan Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 161. Australia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 162. Australia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 163. Australia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 164. Australia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 165. Australia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 166. Australia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 167. Australia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 168. Vietnam Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 169. Vietnam Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 170. Vietnam Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 171. Vietnam Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 172. Vietnam Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 173. Vietnam Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 174. Vietnam Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 175. South Korea Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 176. South Korea Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 177. South Korea Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 178. South Korea Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 179. South Korea Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 180. South Korea Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 181. South Korea Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 182. Indonesia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 183. Indonesia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 184. Indonesia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 185. Indonesia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 186. Indonesia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 187. Indonesia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 188. Indonesia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 189. Philippines Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 190. Philippines Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 191. Philippines Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 192. Philippines Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 193. Philippines Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 194. Philippines Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 195. Philippines Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 196. Middle East & Africa Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 197. Middle East & Africa Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 198. Middle East & Africa Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 199. Middle East & Africa Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 200. Middle East & Africa Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 201. Middle East & Africa Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 202. Middle East & Africa Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 203. Middle East & Africa Patient Engagement Technology Market Share (%), By Country, 2017-2031F
Figure 204. Saudi Arabia Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 205. Saudi Arabia Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 206. Saudi Arabia Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 207. Saudi Arabia Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 208. Saudi Arabia Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 209. Saudi Arabia Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 210. Saudi Arabia Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 211. UAE Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 212. UAE Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 213. UAE Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 214. UAE Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 215. UAE Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 216. UAE Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 217. UAE Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 218. South Africa Patient Engagement Technology Market, By Value, In USD Billion, 2017-2031F
Figure 219. South Africa Patient Engagement Technology Market Share (%), By Component, 2017-2031F
Figure 220. South Africa Patient Engagement Technology Market Share (%), By Delivery Type, 2017-2031F
Figure 221. South Africa Patient Engagement Technology Market Share (%), By Therapeutic Area, 2017-2031F
Figure 222. South Africa Patient Engagement Technology Market Share (%), By Functionality, 2017-2031F
Figure 223. South Africa Patient Engagement Technology Market Share (%), By Application, 2017-2031F
Figure 224. South Africa Patient Engagement Technology Market Share (%), By End-user, 2017-2031F
Figure 225. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 226. By Delivery Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 227. By Therapeutic Area Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 228. By Functionality Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 229. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 230. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 231. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11457

Global patient engagement technology market is projected to witness a CAGR of 15.08% during the forecast period 2024-2031F, growing from USD 20.41 billion in 2023 to USD 62.78 billion in 2031F. The market's growth is supported by the introduction of favorable government policies, rapid population growth, the increasing prevalence of various diseases, the rising usage of mobile applications, and strategic partnerships between various market players. The rising investments towards enhancing IT infrastructure by various healthcare establishments are bolstering the global patient engagement technology market size. The seamless patient assistance offered by these technologies allows healthcare professionals to track patient adherence effectively while ensuring a real-time connection with the patients.

Additionally, the increasing investments by leading companies towards patient engagement startups are expected to support the expansion of the market in the coming years. In April 2024, Providence spun out Praia Health, a platform designed to aid healthcare providers in building strong relationships with their patients by connecting them to helpful services and resources. The Series A funding round was closed at USD 20 million by Frist Cressey Ventures and includes participants such as Providence Ventures, Inc., SignalFire Management Services, L.L.C., and Epsilon Health Investors, LLC. The platform aims to unify fragmented point solutions and data sources, including those designed for billing and care delivery, care navigation, and booking appointments at the consumer level. With the development of such platforms, personalization of the patients' healthcare journeys will become possible, and the healthcare professionals will be provided with an accurate picture of the patient's health.

Increasing Prevalence of Chronic Diseases Boosts Market Demand

The rise in the number of patients living with various chronic diseases in various regions across the globe is one of the major drivers supporting the expansion of the market. According to the estimates of the U.S. Centers for Disease Control and Prevention, approximately 38.4 million individuals (accounting for 11.6% of the population of the United States) are living with diabetes as of 2024. Thus, various companies should be encouraged to invest in the development of patient-centric engagement solutions to ensure the effective management of such diseases.

Patient engagement technologies increase the patient's information accessibility and improve healthcare outcomes. They are also responsible for reducing expenses by streamlining workflow and improving patient coordination. In November 2023, Prisma Health, the largest healthcare provider in South Carolina, announced that they saved USD 4 million within the first two years by incorporating digital patient communication. The healthcare provider made these savings with the help of Artera, the patient engagement company. Meanwhile, to enhance the quality of care provided to the patients, the emphasis on developing novel technologies and launching advanced products is also increasing, resulting in the introduction of novel patient engagement solutions.

Rising Mergers, Collaborations and Acquisitions Support Market Growth

The increasing investments by various companies in developing novel products and software are expected to provide lucrative growth opportunities for the market in the coming years. Such activities support the development of novel products and technologies and allow companies to expand their customer base, increasing patient accessibility to various technologies. In January 2024, Innovaccer Inc., the leading digital healthcare company, announced the acquisition of Cured Inc., a CRM and healthcare digital marketing platform. The deal allowed the digital healthcare company to add 20 new customers to its portfolio of approximately 95 digital health and health system clients. Some of Cured's customers include HonorHealth, VCU Health, Sutter Health, and UCHealth. The accusation is expected to aid Innovaccer in becoming a leader in patient experience technology and execute its forward strategy.

North America Accounts for a Significant Share of the Market

The growth of the market in the region can be attributed to the increasing emphasis on enhancing the quality of care provided to patients, the rapid expansion of the healthcare sector, the strong presence of leading market players, and the rising acceptance of advanced technologies and services. Patient engagement technology allows healthcare professionals to gather actionable patient health data, reducing costs for healthcare providers and patients and enhancing the patient experience, thus bolstering their utilization. The growing efforts of the various companies based in the region towards developing advanced solutions are also supporting the market expansion. For instance, in September 2023, Zocdoc, Inc., one of the leading appointment booking platforms, launched its free suite of tools to aid healthcare providers in managing, keeping, and reaching patients. The company is expected to continue its efforts to support the enhancement of the tools, provide patient-provider messaging, and incorporate additional services such as facilitation of payments, among others, to bolster patient engagement and save time on different admin tasks. Such developments are also expected to support the growth of the region's market in the coming years.

Software Account for Significant Global Patient Engagement Technology Market Share

The software segment will account for a significant market share in the coming years. This growth can be attributed to various healthcare institutions' rising adoption of software to streamline workflow and provide enhanced patient experience. Furthermore, such software also aids in improving the quality of care provided for various chronic diseases and disorders, including cancer. According to the estimates of the National Cancer Institute, in 2022, 20 million new cases of cancer were reported, and the number is expected to increase to 29.9 million by 2040. This increase in cancer cases is propelling the requirement for patient engagement software to enhance oncology care as the software ensures focused patient interaction while providing intelligent symptom management and enabling digital patient monitoring.

Future Market Scenario (2024-2031F)

According to the global patient engagement technology market analysis, the market is expected to receive lucrative growth opportunities in the coming years. Patient engagement tools are expected to be used in research studies as an intervention or treatment for various diseases and disorders. For instance, Stanford University is conducting an interventional study that is expected to conclude in August 2025 to improve access and adherence to overactive bladder treatment with the help of mobile technology-based interventions and personalized behavioral modifications. The study aims to evaluate the effectiveness of a patient-centered tool in initiating the treatment.

Technological innovations in patient engagement are expected to deliver digital healthcare transformation in the coming years. Omnichannel healthcare is expected to become an integral component of healthcare digitalization, aiding patients in receiving a unified pathway to enhance their experience. The digital transformation of the healthcare sector with the help of artificial intelligence is expected to drive the market's growth. Artificial intelligence will allow the completion of various repetitive operations and tasks time-efficiently, enhancing patient experience and ensuring a deeper engagement among patients and their doctors.

Key Players Landscape and Outlook

The increasing partnerships between various market players support the market's growth to elevate the quality of care provided to patients. In April 2024, Linkwell Health, a healthcare-based consumer engagement technology company and Matrix Medical Network, one of the leading providers of in-home health assessments, announced a partnership to boost engagement with Matrix's services and enhance the patient experience. Matrix will be supported by Linkwell with omni-channel engagement journeys to encourage health plan members to take charge of their health. Linkwell's leading patient activation and engagement capabilities are expected to aid the organization in focusing on their core expertise.

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Patient Engagement Technology Market Outlook, 2017-2031F

4.1. Market Size & Forecast
- 4.1.1. By Value
4.2. By Component
- 4.2.1. Software
  - 4.2.1.1. Integrated Software
  - 4.2.1.2. Standalone Software
- 4.2.2. Hardware
  - 4.2.2.1. Tablets
  - 4.2.2.2. In-room Television
  - 4.2.2.3. Integrated Bedside Terminals/Assisted Devices
- 4.2.3. Services
  - 4.2.3.1. Consulting
  - 4.2.3.2. Support and Maintenance
  - 4.2.3.3. Training and Implementation
  - 4.2.3.4. Others
4.3. By Delivery Type
- 4.3.1. On Premise
- 4.3.2. Web and Cloud-based
4.4. By Therapeutic Area
- 4.4.1. Health and Wellness
- 4.4.2. Chronic Disease Management
- 4.4.3. Others
4.5. By Functionality
- 4.5.1. Communication
- 4.5.2. Health Tracking and Insights
- 4.5.3. Billing and Payments
- 4.5.4. Administrative
- 4.5.5. Patient Education
- 4.5.6. Others
4.6. By Application
- 4.6.1. Population Health Management
- 4.6.2. In-patient Health Management
- 4.6.3. Outpatient Health Management
- 4.6.4. Others
4.7. By End-user
- 4.7.1. Healthcare Providers
  - 4.7.1.1. Ambulatory Care Centers
  - 4.7.1.2. Home Healthcare Providers
  - 4.7.1.3. Hospitals
- 4.7.2. Payers
  - 4.7.2.1. Public
  - 4.7.2.2. Private
- 4.7.3. Patients
- 4.7.4. Others
4.8. By Region
- 4.8.1. North America
- 4.8.2. South America
- 4.8.3. Europe
- 4.8.4. Asia-Pacific
- 4.8.5. Middle East and Africa
4.9. By Company Market Share (%), 2023

5. Global Patient Engagement Technology Market Outlook, By Region, 2017-2031F

5.1. North America*
- 5.1.1. Market Size & Forecast
  - 5.1.1.1. By Value
- 5.1.2. By Component
  - 5.1.2.1. Software
    - 5.1.2.1.1. Integrated Software
    - 5.1.2.1.2. Standalone Software
  - 5.1.2.2. Hardware
    - 5.1.2.2.1. Tablets
    - 5.1.2.2.2. In-room Television
    - 5.1.2.2.3. Integrated Bedside Terminals/Assisted Devices
  - 5.1.2.3. Services
    - 5.1.2.3.1. Consulting
    - 5.1.2.3.2. Support and Maintenance
    - 5.1.2.3.3. Training and Implementation
    - 5.1.2.3.4. Others
- 5.1.3. By Delivery Type
  - 5.1.3.1. On Premise
  - 5.1.3.2. Web and Cloud-based
- 5.1.4. By Therapeutic Area
  - 5.1.4.1. Health and Wellness
  - 5.1.4.2. Chronic Disease Management
  - 5.1.4.3. Others
- 5.1.5. By Functionality
  - 5.1.5.1. Communication
  - 5.1.5.2. Health Tracking and Insights
  - 5.1.5.3. Billing and Payments
  - 5.1.5.4. Administrative
  - 5.1.5.5. Patient Education
  - 5.1.5.6. Others
- 5.1.6. By Application
  - 5.1.6.1. Population Health Management
  - 5.1.6.2. In-patient Health Management
  - 5.1.6.3. Outpatient Health Management
  - 5.1.6.4. Others
- 5.1.7. By End-user
  - 5.1.7.1. Healthcare Providers
    - 5.1.7.1.1. Ambulatory Care Centers
    - 5.1.7.1.2. Home Healthcare Providers
    - 5.1.7.1.3. Hospitals
  - 5.1.7.2. Payers
    - 5.1.7.2.1. Public
    - 5.1.7.2.2. Private
  - 5.1.7.3. Patients
  - 5.1.7.4. Others
- 5.1.8. United States*
  - 5.1.8.1. Market Size & Forecast
    - 5.1.8.1.1. By Value
  - 5.1.8.2. By Component
    - 5.1.8.2.1. Software
      - 5.1.8.2.1.1. Integrated Software
      - 5.1.8.2.1.2. Standalone Software
    - 5.1.8.2.2. Hardware
      - 5.1.8.2.2.1. Tablets
      - 5.1.8.2.2.2. In-Room Television
      - 5.1.8.2.2.3. Integrated Bedside Terminals/Assisted Devices
    - 5.1.8.2.3. Services
      - 5.1.8.2.3.1. Consulting
      - 5.1.8.2.3.2. Support and Maintenance
      - 5.1.8.2.3.3. Training and Implementation
      - 5.1.8.2.3.4. Others
  - 5.1.8.3. By Delivery Type
    - 5.1.8.3.1. On Premise
    - 5.1.8.3.2. Web and Cloud-based
  - 5.1.8.4. By Therapeutic Area
    - 5.1.8.4.1. Health and Wellness
    - 5.1.8.4.2. Chronic Disease Management
    - 5.1.8.4.3. Others
  - 5.1.8.5. By Functionality
    - 5.1.8.5.1. Communication
    - 5.1.8.5.2. Health Tracking and Insights
    - 5.1.8.5.3. Billing and Payments
    - 5.1.8.5.4. Administrative
    - 5.1.8.5.5. Patient Education
    - 5.1.8.5.6. Others
  - 5.1.8.6. By Application
    - 5.1.8.6.1. Population Health Management
    - 5.1.8.6.2. In-patient Health Management
    - 5.1.8.6.3. Outpatient Health Management
    - 5.1.8.6.4. Others
  - 5.1.8.7. By End-user
    - 5.1.8.7.1. Healthcare Providers
      - 5.1.8.7.1.1. Ambulatory Care Centers
      - 5.1.8.7.1.2. Home Healthcare Providers
      - 5.1.8.7.1.3. Hospitals
    - 5.1.8.7.2. Payers
      - 5.1.8.7.2.1. Public
      - 5.1.8.7.2.2. Private
    - 5.1.8.7.3. Patients
    - 5.1.8.7.4. Others
- 5.1.9. Canada
- 5.1.10. Mexico

All segments will be provided for all regions and countries covered

5.2. Europe
- 5.2.1. Germany
- 5.2.2. France
- 5.2.3. Italy
- 5.2.4. United Kingdom
- 5.2.5. Russia
- 5.2.6. Netherlands
- 5.2.7. Spain
- 5.2.8. Turkey
- 5.2.9. Poland
5.3. Asia-Pacific
- 5.3.1. India
- 5.3.2. China
- 5.3.3. Japan
- 5.3.4. Australia
- 5.3.5. Vietnam
- 5.3.6. South Korea
- 5.3.7. Indonesia
- 5.3.8. Philippines
5.4. South America
- 5.4.1. Brazil
- 5.4.2. Argentina
5.5. Middle East and Africa
- 5.5.1. Saudi Arabia
- 5.5.2. UAE
- 5.5.3. South Africa

6. Market Mapping, 2023

6.1. By Component
6.2. By Delivery Type
6.3. By Therapeutic Area
6.4. By Functionality
6.5. By Application
6.6. By End-user
6.7. By Region

7. Macro Environment and Industry Structure

7.1. Supply Demand Analysis
7.2. Import Export Analysis
7.3. Value Chain Analysis
7.4. PESTEL Analysis
- 7.4.1. Political Factors
- 7.4.2. Economic System
- 7.4.3. Social Implications
- 7.4.4. Technological Advancements
- 7.4.5. Environmental Impacts
- 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter's Five Forces Analysis
- 7.5.1. Supplier Power
- 7.5.2. Buyer Power
- 7.5.3. Substitution Threat
- 7.5.4. Threat From New Entrant
- 7.5.5. Competitive Rivalry

8. Market Dynamics

8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

9.1. Patent Landscape
9.2. Regulatory Approvals
9.3. Innovations/Emerging Technologies

10. Key Players Landscape

10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

13.1. Oracle Corporation
- 13.1.1. Company Details
- 13.1.2. Key Management Personnel
- 13.1.3. Products and Services
- 13.1.4. Financials (As Reported)
- 13.1.5. Key Market Focus and Geographical Presence
- 13.1.6. Recent Developments
13.2. IQVIA Holdings Inc.
13.3. Koninklijke Philips N.V.
13.4. Klara Technologies, Inc.
13.5. Oneview Healthcare PLC
13.6. Epic Systems Corporation
13.7. Lincor Inc.
13.8. Orion Health Ltd.
13.9. MEDHOST Inc.
13.10. Nuance Communications, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

患者エンゲージメント技術市場の評価：コンポーネント・デリバリータイプ・治療領域・機能・用途・エンドユーザー・地域別の機会および予測 (2017-2031年)

Patient Engagement Technology Market Assessment, By Component, By Delivery Type, By Therapeutic Area, By Functionality, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の患者エンゲージメント技術市場の展望

第5章世界の患者エンゲージメント技術市場の展望：地域別

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

第14章戦略的提言

第15章当社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Patient Engagement Technology Market Outlook, 2017-2031F

5. Global Patient Engagement Technology Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

患者エンゲージメント技術市場の評価：コンポーネント・デリバリータイプ・治療領域・機能・用途・エンドユーザー・地域別の機会および予測 (2017-2031年)

Patient Engagement Technology Market Assessment, By Component, By Delivery Type, By Therapeutic Area, By Functionality, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の患者エンゲージメント技術市場の展望

第5章 世界の患者エンゲージメント技術市場の展望：地域別

第6章 市場マッピング、2023年

第7章 マクロ環境と産業構造

第8章 市場力学

第9章 規制枠組みとイノベーション

第10章 主要企業の情勢

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の展望

第14章 戦略的提言

第15章 当社について・免責事項

List of Tables

List of Figures

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global Patient Engagement Technology Market Outlook, 2017-2031F

5. Global Patient Engagement Technology Market Outlook, By Region, 2017-2031F

6. Market Mapping, 2023

7. Macro Environment and Industry Structure

8. Market Dynamics

9. Regulatory Framework and Innovation

10. Key Players Landscape

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

14. Strategic Recommendations

15. About Us & Disclaimer

第1章調査手法

第2章プロジェクトの範囲と定義

第3章エグゼクティブサマリー

第4章世界の患者エンゲージメント技術市場の展望

第5章世界の患者エンゲージメント技術市場の展望：地域別

第6章市場マッピング、2023年

第7章マクロ環境と産業構造

第8章市場力学

第9章規制枠組みとイノベーション

第10章主要企業の情勢

第11章価格分析

第12章ケーススタディ

第13章主要企業の展望

第14章戦略的提言

第15章当社について・免責事項